Collect. Czech. Chem. Commun. 2004, 69, 1491-1498
https://doi.org/10.1135/cccc20041491

Synthesis and Leukemia Cell Growth Inhibition of a Series of 1,3-Dithiazolylbenzene Derivatives

Irene M. Lagojaa, Koen Nauwelaertsa, Christine Bal-Mahieub, Michela Pasqualinia, Christian Baillyb and Piet Herdewijna,*

a Laboratory of Medicinal Chemistry, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium
b INSERM U-524 et Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, 59045 Lille, France

References

1. Clemence F., Martret O. L., Delevallee F., Benzoni J., Jouanen A., Jouquey S., Mouren M., Deraedt R.: J. Med. Chem. 1988, 31, 1453. <https://doi.org/10.1021/jm00402a034>
2. Tsuji K., Ishikawa H.: Bioorg. Med. Chem. Lett. 1994, 4, 1601. <https://doi.org/10.1016/S0960-894X(01)80574-6>
3. Bell F., Cantrell A. S., Hogberg M., Jaskunas S. R., Johansson N. G., Jordon C. L., Kinnik M. D., Lind P., Morin J. M., Jr., Noréen R., Öberg B., Palkowitz J. A., Parrish C. A., Pranc P., Sahlberg C., Ternansky R. J., Vasileff R. T., Vrang L., West S. J., Zhang H., Zhou X. X.: J. Med. Chem. 1995, 38, 4929. <https://doi.org/10.1021/jm00025a010>
4. Badorc A., Bordes M.-F., de Cointet P., Savi P., Bernat A., Lalé A., Petitou M., Maffrand J.-P., Herbert J.-M.: J. Med. Chem. 1997, 40, 3393. <https://doi.org/10.1021/jm970240y>
5. Rudolph J., Theis H., Hanke R., Endermann R., Johannsen L., Geschke F.-U.: J. Med. Chem. 2001, 44, 619. <https://doi.org/10.1021/jm0010623>
6. Chong W. K. M., Chu S. S., Duvadie R. R., Li L., Xiao W., Yang Y. (Agouran Pharmaceuticals Inc.): WO 99/21845 1999.
7a. Horning S. J., Adhikari A., Rizk N., Hoppe R. T., Olshen R. A.: J. Clin. Oncol. 1994, 12, 297. <https://doi.org/10.1200/JCO.1994.12.2.297>
7b. Glick J. H., Young M. L., Harrington D., Schilsky R. L., Beck T., Neiman R., Fisher R. I., Peterson B. A., Oken M. M.: J. Clin. Oncol. 1998, 16, 19. <https://doi.org/10.1200/JCO.1998.16.1.19>
8a. Hantzsch A., Weber H. J.: Ber. Dtsch. Chem. Ges. 1887, 20, 3118. <https://doi.org/10.1002/cber.188702002200>
8b. Hantzsch A.: Ber. Dtsch. Chem. Ges. 1890, 23, 1474. <https://doi.org/10.1002/cber.189002301243>
8c. Schantl J. G., Lagoja I. M.: Synth. Commun. 1998, 28, 1451. <https://doi.org/10.1080/00397919808006844>
9. Dehne H., Maass V.: Z. Chem. 1988, 28, 296. <https://doi.org/10.1002/zfch.19880280816>
10. Weber W., Leibfritz D., Kerssebaum R., Bernel W.: Magn. Res. Chem. 1993, 31, 287.
11. CS Chem3D Pro, © 1997. Cambridge Soft Corporation 875, Massachusetts Avenue, Cambridge (MA), 02139 U.S.A.
12. Becker E. D.: High Resolution NMR, Theory and Chemical Application, p. 169. Academic Press, New York 1969.
13. States D. J., Haberkorn R. A., Ruben D. J.: J. Magn. Res. 1982, 48, 286.
14. Lagoja I. M., Pannecouque C., Van Aerschot A., Witvrouw M., Debyser Z., Balzarini J., Herdewijn P., De Clercq E.: J. Med. Chem. 2003, 46, 1546. <https://doi.org/10.1021/jm0211117>
15a. David-Cordonnier M.-H., Laine W., Joubert A., Tardy C., Goossens J.-F., Kouach M., Briand G., Thi Mi H. D., Michel S., Tillequin F., Koch M., Leonce S., Pierre A., Bailly C.: Eur. J. Biochem. 2003, 270, 2848. <https://doi.org/10.1046/j.1432-1033.2003.03663.x>
15b. Kluza J., Lansiaux A., Wattez N., Hildebrand M. P., Léonce S., Pierré A., Hickman J. A., Bailly C.: Biochem. Pharmacol. 2000, 63, 1443. <https://doi.org/10.1016/S0006-2952(02)00899-7>
15c. Kluza J., Lansiaux A., Wattez N., Mahieu C., Osheroff N., Bailly C.: Cancer Res. 2000, 60, 4077.
15d. Lansiaux A., Facompré M., Wattez N., Hildebrand M. P., Bal C., Demarquay D., Lavergne O., Bigg D. C. H., Bailly C.: Mol. Pharmacol. 2001, 60, 450.